Delivery Order SPE2DB20D3103-SPE2DB24FL8H8

Award Date 12/8/23
Potential Completion Date 12/11/23
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,315.75 firm fixed-price delivery order is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty pharmaceutical product. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,742.93 Firm Fixed Price Delivery Order contract is for the provision of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,304.26 firm fixed-price delivery order is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,272.72 Firm Fixed Price Delivery Order covers the procurement of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty pharmaceutical product. The contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,319.88 firm fixed-price delivery order is for FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has an ultimate completion date of March 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is a delivery order valued at $7,706.05 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a period of performance through December 16, 2024. Additionally, AmerisourceBergen holds two Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,731.39 firm fixed-price delivery order is for FERAHEME 510 MG/17 ML VIAL 17ML, a medical supply product. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $2,358.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a completion date of February 18, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. AmerisourceBergen holds a significant...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award value of $3,131.61 and is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of February 21, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $11,874.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product, to support federal healthcare programs. The contract has a completion date of January 27, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FL8H8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML. The contract is a Firm Fixed Price Delivery Order valued at $15,154.32 with a completion date of December 11, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 10:36 AM